Catalyst Wire Dossier Catalyst Wire Dossier

CUDC-101

· Curis, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CUDC-101, covering 2015-10-16 to 2015-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors [Phase 1]

See pricing